Lantheus Holdings, Inc. (NASDAQ:LNTH) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds.
Lantheus Holdings, Inc. (NASDAQ:LNTH) is given the fourth position on our list of cheap pharmaceutical stocks.
TheFly reported on January 29 that TD Cowen lowered its price target on LNTH to $75 from $80 and gave it a Buy rating. The firm also updated its financial model in anticipation of the company’s upcoming fourth-quarter results.
Earlier, on January 2, Lantheus Holdings, Inc. (NASDAQ:LNTH) officially announced the completion of its previously planned divestiture of the Single Photon Emission Computed Tomography (SPECT) business to SHINE Technologies. LNTH’ diagnostic agents, the SPECT product manufacturing area of its North Billerica, Massachusetts site, and SPECT-related activities in Canada were all included in the sale. LNTH may reorganize its operations and concentrate on regions with more growth potential and profits thanks to this strategic transaction.
The company’s growth of its commercial portfolio in PET radiodiagnostics, which comprises sophisticated imaging solutions, and its microbubble products used in contrast-enhanced ultrasound procedures, will be its top priorities going forward. In order to position the business for long-term growth in precision imaging and targeted treatments, LNTH will simultaneously keep investing in and developing its pipeline of radiopharmaceuticals. The company will use its knowledge of nuclear medicine to create novel diagnostic and therapeutic solutions for patients.
Lantheus Holdings, Inc. (NASDAQ:LNTH) is a U.S. radiopharmaceutical leader developing and commercializing innovative precision diagnostics and oncology imaging agents that help clinicians detect and monitor disease.
While we acknowledge the potential of LNTH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Unstoppable Dividend Stocks to Buy According to Analysts and Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks.
Disclosure: None.
